Veradigm | MDRX - Capitaux Propres Et Réserves

Prix De L'Action
4.55
Variation Quotidienne
-0.03 -0.66%
Mensuellement
1.11%
Annuel
4.36%
Q1 Prévisions
4.44




Capitaux Propres Et Réserves Changement Date
Alcidion AUD 89.64M 1.84M 2025-12
Ambu A/S DKK 6.04B 1000K 2025-12
Amplifon EUR 970.08M 43.75M 2025-09
Cardinal Health USD -2.88B 5M 2025-12
Centene USD 19.95B 995M 2025-12
Charles River Laboratories USD 3.16B 240.82M 2025-12
Cigna USD 41.71B 92M 2025-12
Coloplast 13.8B 2.32B 2025-12
Computer Programs Systems USD 180.36M 7.18M 2025-09
Convatec Group USD 1.69B 34M 2024-12
CVS Health USD 75.21B 2.29B 2025-12
Diasorin EUR 1.53B 151.64M 2025-06
Elevance Health USD 44.03B 73M 2025-12
General Electric Aerospace USD 18.9B 86M 2025-12
Gulf Medical Proj AED 1.22B 56.38M 2025-12
Humana USD 17.66B 865M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Maximus USD 1.72B 45.78M 2025-12
McKesson USD -1.3B 441M 2025-12
Med Life RON 483.77M 18.26M 2025-12
Molina Healthcare USD 4.07B 122M 2025-12
Omnicell USD 1.22B 42.72M 2025-09
Oriola-kd EUR 100.8M 17.1M 2025-12
Owens Minor USD -460.98M 31.47M 2025-12
Quest Diagnostics USD 7.17B 88M 2025-12
Rede D'or Sao Luiz BRL 19.35B 9.45B 2025-12
Siemens Healthineers EUR 18.43B 389M 2025-12
Sonova Holding CHF 2.66B 374.5M 2025-06
Supermax Corporation Bhd MYR 3.81B 124.21M 2025-12
UnitedHealth USD 105.81B 1.03B 2025-09
Veeva Systems USD 7.21B 174.12M 2025-12
Veradigm USD 1.02B 159.52M 2022-12
Xerox USD 365M 757M 2025-09